Hague Corp Announces Solterra has Concluded Worldwide Exclusive License with Rice University

Hague Corp, a resource exploration company, has announced that Solterra Renewable Technologies, Inc. has concluded the worldwide exclusive license with the William Marsh Rice University for intellectual property which includes the "Synthesis of Uniform Nanoparticle Shapes with High Selectivity." The licensing agreement field of use broadly covers the manufacture and sale of photovoltaic cells and the manufacture and sales of quantum dots for electronic and medical applications. Hague and Solterra announced they had entered into a binding letter of intent on October 3, 2008.

Rice University’s breakthrough discovery has been the highlight of numerous scientific journal articles and has gained the attention of mainstream news media. This new chemical method for making low cost, four-legged cadmium selenide quantum dots, which previous research has shown to be particularly effective at converting sunlight into electrical energy, knocks down a major barrier in developing quantum-dot-based photovoltaics as an alternative to the conventional, more expensive silicon-based solar cells.

“The lack of low cost, high-quality tetrapods of the cadmium selenide kind has been a major roadblock in developing tetrapod-based solar cell devices. With this breakthrough technology that is no longer the case,” said Stephen B. Squires, CEO and President of Solterra Renewable Technologies, Inc. Squires continued with, “We believe that we are now positioned to revolutionize the solar panel industry in offering the most cost effective and efficient panels ever produced at a time that they are more in demand than ever before.”

The Rice process produces same-sized particles, in which more than 90 percent are tetrapods; previously even in the best recipe less than 50 percent of the prepared particles were tetrapods. Furthermore, the Rice process uses much cheaper raw materials and fewer purification steps reducing the production cost by 80% or more. A positively charged molecule called cetyltrimethylammonium bromide provides this drastic improvement in tetrapod manufacture. This compound, found in some shampoos, also happens to be 100 times cheaper than alkylphosphonic acids and is far safer, further simplifying the manufacturing process.

In addition to photovoltaic applications low cost high quality quantum dots are widely thought to be the enabling factor for a variety of other emerging technologies including high performance QD based lasers, color displays, solid state lighting, bioimaging, quantum computers and solar/hydrogen generation.

Solterra is scheduled to begin scale up of this revolutionary technology in early November 2008 with commercial production anticipated to begin in the second half of 2009.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Solterra Renewable Technologies. (2019, February 15). Hague Corp Announces Solterra has Concluded Worldwide Exclusive License with Rice University. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=8276.

  • MLA

    Solterra Renewable Technologies. "Hague Corp Announces Solterra has Concluded Worldwide Exclusive License with Rice University". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=8276>.

  • Chicago

    Solterra Renewable Technologies. "Hague Corp Announces Solterra has Concluded Worldwide Exclusive License with Rice University". AZoNano. https://www.azonano.com/news.aspx?newsID=8276. (accessed April 19, 2024).

  • Harvard

    Solterra Renewable Technologies. 2019. Hague Corp Announces Solterra has Concluded Worldwide Exclusive License with Rice University. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=8276.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.